跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AURO-RISEDRONATE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
AURO-RISEDRONATE
Authorized
STANDARD
AURO-RISEDRONATE
auro pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
ddf60ae40a2f4a69
Company
auro pharma inc
Type
Standard
Approval Details
Approval Id
ddf60ae40a2f4a69
Drug Approval Canada Name
AURO-RISEDRONATE
Product Name
AURO-RISEDRONATE
Status
Dormant
Status Date
2020-07-24
Original Market Date
2016-04-13
Din
02442760
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
92:24.00
Atc Original
M05BA07 RISEDRONIC ACID
Atc Name
m 05 ba 07
Aig Number
0135301005
Company Name
auro pharma inc
Company Address
3700 Steeles Avenue West, Suite 402, Woodbridge, Ontario, Canada, L4L 8K8
Active Ingredients
RISEDRONATE SODIUM (RISEDRONATE SODIUM HEMIPENTAHYDRATE)
150 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
ddf60ae40a2f4a69
Type
Standard
Back to Health Canada Approvals